This article is part of the network’s archive of useful research information. This article is closed to new comments due to inactivity. We welcome new content which can be done by submitting an article for review or take part in discussions in an open topic or submit a blog post to take your discussions online.
A novel application utilising data from the US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) has been developed by a Biomedical Informatics team at the Cincinnati Children’s Hospital Medical Center.
AERSMine has been developed to allow users to analyse and identify differential clinical outcomes to various drug regimes, within different patient subgroups and accounting for other treatment-related factors.
Read more about the tool:
And have a go at the tool yourself by clicking here.